Contributors: Vilnius University Vilnius; Institut National de la Santé et de la Recherche Médicale (INSERM); Minister of Health; Minister of Health, Kiev; Minister of Labour, Health and Social Affairs; Minister of Health, Labour and Social Protection; European Parliament, Perugia; European Parliament, Helsinki; Lithuianian Academy of Sciences, Vilnius; Transilvania University of Brasov; Global Alliance Against Chronic Respiratory Diseases (GARD); Imperial College London; Tbilisi State Medical University (Department of Pediatrics); Danylo Halytskiy Lviv National Medical University; VU University Medical Center Amsterdam; Queen Mary University of London (QMUL); Helsingin yliopisto = Helsingfors universitet = University of Helsinki; Tartu University Hospital; Vinnytsa National Medical University by Mykola Pyrogov; Global Alliance Against Chronic Respiratory Diseases (GARD-WHO); Europeays Diseases Patientn Federation of Allergy and Airwas' Associations (EFA); European Federation of Allergy and Airways Diseases Patients' Associations (EFA); Association of Medical Schools in Europe; State Institute of Phtysiopulmonology by Chiril Draganiuk; European Academy of Paediatrics (EAP/UEMS-SP); Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR); Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA); Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office Genève, Suisse (OMS / WHO); iQ4U consultants Ltd; Institute of Tuberculosis and Lung Diseases Warsaw, Poland (ITLD); European University of Cyprus, Cyprus; Institute of Medical Research Tbilisi, Georgia; Ilia State University Tbilisi; Danish Commitee for Health Education; Department of Prevention of Environmental Hazards and Allergology; Warszawski Uniwersytet Medyczny Polska = Medical University of Warsaw Poland = Université de Médecine de Varsovie Pologne -Faculté de Pharmacie de Paris; Yerevan State University; Lithuanian University of health Sciences (LSMU); European Health Futures Forum (EHFF); Hospital of Lithuanian University of Health Sciences Kauno Klinikos Kaunas, Lithuania; University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA)
Abstract: International audience ; Over 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea.Conclusion: The Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.
Processing Request
No Comments.